RheumNow/LinkedIn
Jan 11, 2026, 09:58
Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
RheumNow shared a post on LinkedIn about a paper by Beatriz Grand et al. published in Lupus:
“100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significantly more prevalent in PE women (34% vs 10%) [OR = 4.63]. aPL positivity was also linked to both early and late severe PE [OR = 4-5, p = .008].”
Title: Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study
Authors: Beatriz Grand, Sebastián Udry, Andrea Avigliano, Mónica González Alcántara, José Omar Latino, Liliana Susana Voto
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 28, 2026, 03:17New Insights on ART Use Among TNB Individuals Unveiled – RBMO
-
Feb 28, 2026, 03:12Horace Roman: Advancing Endometriosis Care Through International Collaboration
-
Feb 27, 2026, 13:58New Nomogram Enhances Preterm Birth Risk Assessment – AJOG MFM
-
Feb 27, 2026, 13:45Alberto Sifuentes Giraldo: Innovative CAR–T Cell Therapy Promises SLE Remission and Fertility
-
Feb 27, 2026, 13:27Ovarian Reserve’s Impact on Miscarriage Risk – RBMO
-
Feb 27, 2026, 13:12ACOG’s Outstanding Editorial Team for Menopause – ACOG
-
Feb 27, 2026, 11:26Phase-Dependent Cytokine Dynamics of Endometrium – Fertility and Sterility
-
Feb 27, 2026, 08:51Pregnancy with Lupus Is No Longer a Distant Possibility – The Lupus Foundation of Australia
-
Feb 27, 2026, 08:43Celebrate Your Triumphs: Share Your Joyful Milestones – ASRM